Abstract.
Betaine homocysteine methyltransferase (BHMT), a Zn2+-dependent thiolmethyltransferase, contributes to the regulation of homocysteine levels, increases in which are considered a risk factor for cardiovascular diseases. Most plasma homocysteine is generated through the liver methionine cycle, in which BHMT metabolizes approximately 25% of this non-protein amino acid. This process allows recovery of one of the three methylation equivalents used in phosphatidylcholine synthesis through transmethylation, a major homocysteine-producing pathway. Although BHMT has been known for over 40 years, the difficulties encountered in its isolation precluded detailed studies until very recently. Thus, the last 10 years, since the sequence became available, have yielded extensive structural and functional data. Moreover, recent findings offer clues for potential new functions for BHMT. The purpose of this review is to provide an integrated view of the knowledge available on BHMT, and to analyze its putative roles in other processes through interactions uncover to date.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 26 May 2006; received after revision 3 July 2006; accepted 24 August 2006
Rights and permissions
About this article
Cite this article
Pajares, M.A., Pérez-Sala, D. Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism?. Cell. Mol. Life Sci. 63, 2792–2803 (2006). https://doi.org/10.1007/s00018-006-6249-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-006-6249-6